Clinigen, a UK-based medical and pharmaceutical services provider, has announced the establishment of its first wholly owned subsidiary in mainland China, located in Shanghai’s Waigaoqiao Free Trade Zone. This new unit is set to capitalize on the zone’s policy benefits, including streamlined customs clearance, investment management, and cross-border investment and financing, along with the global resources of its parent company, to develop a comprehensive global full lifecycle pharmaceutical service platform.
Clinigen, known for its specialized pharmaceutical services, is dedicated to ensuring ethical access to medicines with a focus on delivering the right medicine to the right patient at the right time. The company provides support to pharmaceutical and biotech companies across the entire medical product lifecycle, from clinical stages to commercialization. Clinigen operates from various sites across North America, Europe, Africa, and the Asia Pacific, boasting a workforce of over 1,200 employees spread across 15 countries on five continents. The company’s reach extends to more than 120 countries annually, providing access to vital medicines where they are needed most.- Flcube.com
